Skip to main content
. 2016 May 6;19(10):pyw049. doi: 10.1093/ijnp/pyw049

Table 1.

Overview of Mean Demographic Data and Questionnaire Scores for Healthy Controls and the aADHD MPH and Placebo Groups

First Appointment First Appointment Second Appointment
All Participants Controls ADHD aADHD Group Placebo MPH Placebo MPH
Participants (male) 29 (13) 29 (18) Participants (male) 14 (8) 15 (10) 13 (7) 14 (9)
Mean age 33.3 (9.3) 36.1 (9.9) Mean age 35.5 (10.1) 36.7 (10.0) 36.4 (9.9) 37.3 (10.1)
Mean school years 11.1 (1.8) 10.8 (1.6) Mean school years 10.5 (1.4) 11.2 (1.8) 10.5 (1.5) 11.4 (1.7)
SPM raw score 50.7 (4.9) 49.4 (7.0) SPM raw score 49.0 (8.0) 49.8 (6.1) 49.2 (8.2) 49.6 (6.3)
ASRS CAARS DSM-IV Symptoms
 Inattention 11.2 (4.6)*** 24.0 (4.8)***  Inattentive 77.4 (10.0) 80.0 (9.1) 69.1 (12.8) 61.6 (12.7)
 Hyperactivity/Impulsivity 9.7 (5.4)*** 18.7 (6.2)***  Hyperactive/impulsive 65.3 (13.0) 55.8 (15.1) 56.1 (13.9) 45.1 (11.9)
 Total 75.9 (11.3) 71.5 (11.7) 64.7 (13.8) 54.5 (12.6)
HAM-A 9.3 (8.5) 8.5 (8.0) 6.0 (5.1) 7.0 (7.0)
HAM-D 5.5 (5.8) 4.6 (6.0) 2.4 (2.3) 3.9 (6.0)

Abbreviations: ASRS: Adult ADHD Self-Report Scale; CAARS: Conners’ Adult ADHD Rating Scales; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Depression Rating Scale; MPH: Methlyphenidate; SPM: Standard Progressive Matrices.

Standard deviation is noted in parentheses unless stated otherwise.

*** significant between-group differences, P ≤ .001.